These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27645107)

  • 1. Potential synergistic action of 19 schizophrenia risk genes in the thalamus.
    Richard EA; Khlestova E; Nanu R; Lisman JE
    Schizophr Res; 2017 Feb; 180():64-69. PubMed ID: 27645107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMDAR antagonist action in thalamus imposes δ oscillations on the hippocampus.
    Zhang Y; Yoshida T; Katz DB; Lisman JE
    J Neurophysiol; 2012 Jun; 107(11):3181-9. PubMed ID: 22423006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delta frequency optogenetic stimulation of the thalamic nucleus reuniens is sufficient to produce working memory deficits: relevance to schizophrenia.
    Duan AR; Varela C; Zhang Y; Shen Y; Xiong L; Wilson MA; Lisman J
    Biol Psychiatry; 2015 Jun; 77(12):1098-107. PubMed ID: 25891221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of NMDARs in the Nucleus Reticularis of the Thalamus Produces Delta Frequency Bursting.
    Zhang Y; Llinas RR; Lisman JE
    Front Neural Circuits; 2009; 3():20. PubMed ID: 20057928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of GluN2C-Containing NMDA Receptors in Ketamine's Psychotogenic Action and in Schizophrenia Models.
    Khlestova E; Johnson JW; Krystal JH; Lisman J
    J Neurosci; 2016 Nov; 36(44):11151-11157. PubMed ID: 27807157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A thalamo-hippocampal-ventral tegmental area loop may produce the positive feedback that underlies the psychotic break in schizophrenia.
    Lisman JE; Pi HJ; Zhang Y; Otmakhova NA
    Biol Psychiatry; 2010 Jul; 68(1):17-24. PubMed ID: 20553749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia.
    Smith RE; Haroutunian V; Davis KL; Meador-Woodruff JH
    Am J Psychiatry; 2001 Sep; 158(9):1393-9. PubMed ID: 11532723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dopamine d(2) receptor binding in subregions of the thalamus in schizophrenia.
    Yasuno F; Suhara T; Okubo Y; Sudo Y; Inoue M; Ichimiya T; Takano A; Nakayama K; Halldin C; Farde L
    Am J Psychiatry; 2004 Jun; 161(6):1016-22. PubMed ID: 15169689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMDA receptor hypofunction and the thalamus in schizophrenia.
    Vukadinovic Z
    Physiol Behav; 2014 May; 131():156-9. PubMed ID: 24792662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early-life lead exposure recapitulates the selective loss of parvalbumin-positive GABAergic interneurons and subcortical dopamine system hyperactivity present in schizophrenia.
    Stansfield KH; Ruby KN; Soares BD; McGlothan JL; Liu X; Guilarte TR
    Transl Psychiatry; 2015 Mar; 5(3):e522. PubMed ID: 25756805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia.
    Buchsbaum MS; Christian BT; Lehrer DS; Narayanan TK; Shi B; Mantil J; Kemether E; Oakes TR; Mukherjee J
    Schizophr Res; 2006 Jul; 85(1-3):232-44. PubMed ID: 16713185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subthreshold delta-frequency resonance in thalamic reticular neurons.
    Ulrich D
    Eur J Neurosci; 2014 Aug; 40(4):2600-7. PubMed ID: 24891125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous Gamma Activity in Schizophrenia.
    Hirano Y; Oribe N; Kanba S; Onitsuka T; Nestor PG; Spencer KM
    JAMA Psychiatry; 2015 Aug; 72(8):813-21. PubMed ID: 25587799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GluN2D N-Methyl-d-Aspartate Receptor Subunit Contribution to the Stimulation of Brain Activity and Gamma Oscillations by Ketamine: Implications for Schizophrenia.
    Sapkota K; Mao Z; Synowicki P; Lieber D; Liu M; Ikezu T; Gautam V; Monaghan DT
    J Pharmacol Exp Ther; 2016 Mar; 356(3):702-11. PubMed ID: 26675679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The N-Methyl d-Aspartate Glutamate Receptor Antagonist Ketamine Disrupts the Functional State of the Corticothalamic Pathway.
    Anderson PM; Jones NC; O'Brien TJ; Pinault D
    Cereb Cortex; 2017 Jun; 27(6):3172-3185. PubMed ID: 27261525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local NMDA receptor hypofunction evokes generalized effects on gamma and high-frequency oscillations and behavior.
    Lee J; Hudson MR; O'Brien TJ; Nithianantharajah J; Jones NC
    Neuroscience; 2017 Sep; 358():124-136. PubMed ID: 28676240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of NMDA receptor subunit and post-synaptic density protein expression in the thalamus of elderly patients with schizophrenia.
    Clinton SM; Haroutunian V; Meador-Woodruff JH
    J Neurochem; 2006 Aug; 98(4):1114-25. PubMed ID: 16762023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The thalamic mGluR1-PLCβ4 pathway is critical in sleep architecture.
    Hong J; Lee J; Song K; Ha GE; Yang YR; Ma JS; Yamamoto M; Shin HS; Suh PG; Cheong E
    Mol Brain; 2016 Dec; 9(1):100. PubMed ID: 27998287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eeg alpha rhythm and glucose metabolic rate in the thalamus in schizophrenia.
    Danos P; Guich S; Abel L; Buchsbaum MS
    Neuropsychobiology; 2001; 43(4):265-72. PubMed ID: 11340367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.
    Lisman JE; Coyle JT; Green RW; Javitt DC; Benes FM; Heckers S; Grace AA
    Trends Neurosci; 2008 May; 31(5):234-42. PubMed ID: 18395805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.